Health department won’t subsidise HIV prevention drug

Truvada is a once-daily pill that costs about $750 a month and is aimed at preventing HIV transmission. Photograph: Justin Sullivan/Getty Images An HIV prevention drug will not be taxpayer-subsidised after it failed to receive recommendation to the Pharmaceutical Benefits Scheme.
View More/Source Article